A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.
Clinical trial NCT07358156 · RECRUITING
Trial details
- NCT number
- NCT07358156
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-09
- Primary completion
- 2026-11-16
- Enrollment
- 519
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.